Clonazepam Tablet, Orally Disintegrating
Product Images NDC 72888-136

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Clonazepam (NDC 72888-136). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clonazepam Orally Disintegrating Tablets, Usp 0.125 mg (NDC 72888-133-31)

Clonazepam Orally Disintegrating Tablet, USP, 0.125 mg blister card label from Advagen Pharma Limited. The label indicates each tablet contains 0.125 mg clonazepam and includes warnings for phenylketonurics about phenylalanine content (0.56 mg per tablet). The label features batch details, manufacturer license number KD-682, revision date 10/22, and barcodes. The cards are designed with peel sections for tablet removal.*

FDA Label Image

Clonazepam Orally Disintegrating Tablets, Usp 0.125 mg (NDC 72888-133-29)

Packaging label for Clonazepam Orally Disintegrating Tablets, USP 0.125 mg by Advagen Pharma Ltd. The label shows 60 unit dose tablets (10 blister cards with 6 tablets each) with the NDC 72888-133-29. It includes storage instructions, phenylketonurics content, manufacturer details, and a barcode.*

FDA Label Image

Clonazepam Orally Disintegrating Tablets, Usp 0.25 mg (NDC 72888-134-31)

Blister card packaging for clonazepam orally disintegrating tablets, USP, 0.25 mg strength. Each unit dose is marked with 'DO NOT PUSH' and a warning for phenylketonurics stating the tablet contains 0.56 mg phenylalanine. Distributed by Advagen Pharma Limited, manufacturing lot and expiration date fields are present but not filled. The card contains six tablet compartments with peel lines separating them.*

FDA Label Image

Clonazepam Orally Disintegrating Tablets, Usp 0.25 mg (NDC 72888-134-29)

Packaging label for Clonazepam Orally Disintegrating Tablets, USP, 0.25 mg strength. The product is distributed by Advagen Pharma Ltd and manufactured by Rubicon Research Ltd. The label indicates a package count of 60 unit dose tablets (10 blister cards of 6 tablets each) and includes storage instructions and a barcode. The DEA schedule IV symbol is also visible on the label.*

FDA Label Image

Clonazepam Orally Disintegrating Tablets, Usp 0.5 mg (NDC 72888-135-31)

Label for clonazepam orally disintegrating tablets, USP, 0.5 mg strength, distributed by Advagen Pharma Limited. The label includes warnings for phenylketonurics about phenylalanine content (0.56 mg per tablet), manufacturing license number KD-682, revision date 10/22, and barcode information. The label advises not to push, with space for lot number and expiration date.*

FDA Label Image

Clonazepam Orally Disintegrating Tablets, Usp 0.5 mg (NDC 72888-135-29)

Packaging label for Clonazepam Orally Disintegrating Tablets, USP 0.5 mg by Advagen Pharma Ltd. The label indicates a package of 60 tablets (10 blister cards of 6 tablets each), for oral use with prescription only. It includes storage instructions, phenylketonurics warning, and distributor and manufacturer details.*

FDA Label Image

Clonazepam Orally Disintegrating Tablets, Usp 1 mg (NDC 72888-136-31)

Label for clonazepam orally disintegrating tablets, USP 1 mg, distributed by Advagen Pharma Limited. The label includes warnings for phenylketonurics about phenylalanine content (0.56 mg per tablet), manufacturing license number KD-682, revision date 10/22, and barcodes. The label instructs not to push the tablet through the foil and features the Roman numeral IV indicating the controlled substance schedule.*

FDA Label Image

Clonazepam Orally Disintegrating Tablets, Usp 1 mg (NDC 72888-136-29)

Clonazepam Orally Disintegrating Tablets USP 1 mg packaging label from Advagen Pharma Ltd. The label displays the NDC 72888-136-29, indicates the product is by prescription only, and contains 60 unit dose tablets (10 blister cards of 6 tablets each). The label includes storage instructions, phenylalanine content warning, manufacturer and distributor information, and a barcode.*

FDA Label Image

Clonazepam Orally Disintegrating Tablets, Usp 2 mg (NDC 72888-137-31)

This packaging label depicts clonazepam orally disintegrating tablets, USP, 2 mg strength. Each label includes warnings for phenylketonurics about phenylalanine content, the distributor Advagen Pharma Limited, manufacturing lot number and expiration date fields, a barcode, and instructions not to push the tablets through the packaging. The label also shows the Roman numeral IV and peel guides for separating individual doses.*

FDA Label Image

Clonazepam Orally Disintegrating Tablets, Usp 2 mg (NDC 72888-137-29)

Box packaging label for Clonazepam Orally Disintegrating Tablets, USP 2 mg by Advagen Pharma Ltd. It contains 60 unit dose tablets (10 blister cards with 6 tablets each), prescription only. The label includes storage instructions, phenylketonurics warning, distributed by Advagen Pharma Ltd, manufactured by Rubicon Research Ltd, and a barcode.*

FDA Label Image

Image (Clonazepam Odt Civ)

FDA Label Image

Image (Clonazepam Odt Dosage Imprint)

Clonazepam orally disintegrating tablet marking guide showing dosage strengths: 0.125 mg (B1), 0.25 mg (B2), 0.5 mg (B3), 1 mg (B4), and 2 mg (B5). Each strength is accompanied by a circle with the corresponding code inside and an arrow symbol next to it. Labeler: Advagen Pharma Ltd.*

FDA Label Image

Image Description (Clonazepam Odt Structure)

Chemical structure of clonazepam, showing its fused benzodiazepine ring with nitro, chlorine, and keto substituents as part of its molecular configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.